[Form 4] Kellanova Insider Trading Activity
The W.K. Kellogg Foundation Trust reported a sale of 114,599 shares of Kellanova common stock on 08/28/2025 at a price of $79.5546 per share, reducing the Trust's reported position to 45,097,438 shares. The filing identifies the Trust as a reporting person with director status and a 10% owner. The Form 4 states the sales were executed pursuant to trading instructions given May 7, 2024 that are intended to comply with Rule 10b5-1(c). The filing lists LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company as Trustees and the W.K. Kellogg Foundation as sole beneficiary.
Il W.K. Kellogg Foundation Trust ha comunicato la vendita di 114.599 azioni ordinarie Kellanova in data 28/08/2025 al prezzo di $79,5546 per azione, riducendo la posizione dichiarata del Trust a 45.097.438 azioni. Il deposito identifica il Trust come persona soggetta a comunicazione con status di amministratore e con una partecipazione del 10%. Il Modulo 4 indica che le vendite sono state effettuate in base a istruzioni di negoziazione impartite il 7 maggio 2024, volte a conformarsi alla Regola 10b5-1(c). Nel deposito sono elencati come fiduciari LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas e The Northern Trust Company, mentre beneficiaria unica risulta la W.K. Kellogg Foundation.
El W.K. Kellogg Foundation Trust inform贸 la venta de 114.599 acciones ordinarias de Kellanova el 28/08/2025 a un precio de $79,5546 por acci贸n, reduciendo la posici贸n declarada del Trust a 45.097.438 acciones. la presentaci贸n identifica al Trust como persona obligada a informar con estatus de director y un propietario del 10%. El Formulario 4 indica que las ventas se ejecutaron conforme a instrucciones de negociaci贸n dadas el 7 de mayo de 2024, destinadas a cumplir con la Regla 10b5-1(c). La presentaci贸n enumera como fiduciarios a LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas y The Northern Trust Company, y a la W.K. Kellogg Foundation como beneficiaria 煤nica.
W.K. Kellogg Foundation Trust電� 2025雲� 8鞗� 28鞚� Kellanova 氤错喌欤� 114,599欤茧ゼ 欤茧嫻 $79.5546鞐� 毵る弰頄堧嫟瓿� 氤搓碃頄堨溂氅�, 鞚措鞃� 鞁犿儊鞚� 氤搓碃霅� 氤挫湢霟夓潃 45,097,438欤�搿� 欷勳棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞁犿儊鞚� 鞚挫偓 歆�鞙� 氚� 10% 靻岇湢鞛愲靹� 鞁犼碃 雽�靸侅瀯鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕 4電� 頃措嫻 毵る弰臧� 2024雲� 5鞗� 7鞚检棎 鞝滉车霅� 瓯半灅 歆�旃棎 霐半澕 鞁ろ枆霅橃棃鞙茧┌ 鞚措姅 攴滌箼 10b5-1(c)鞚� 欷�靾橅晿旮� 鞙勴暅 瓴冹澊霛缄碃 氚濏様鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞁犿儊甏�毽澑鞙茧 LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas 氚� The Northern Trust Company臧� 旮办灛霅橃柎 鞛堨溂氅�, 雼弲 靾橃澋鞛愲姅 W.K. Kellogg Foundation鞛呺媹雼�.
Le W.K. Kellogg Foundation Trust a d茅clar茅 la vente de 114 599 actions ordinaires Kellanova le 28/08/2025 au prix de 79,5546 $ par action, r茅duisant la position d茅clar茅e du Trust 脿 45 097 438 actions. Le d茅p么t identifie le Trust comme une personne tenue de d茅clarer, avec le statut d'administrateur et en tant que propri茅taire de 10 %. Le formulaire 4 indique que les ventes ont 茅t茅 ex茅cut茅es conform茅ment aux instructions de n茅gociation donn茅es le 7 mai 2024, visant 脿 se conformer 脿 la r猫gle 10b5-1(c). Le d茅p么t 茅num猫re LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas et The Northern Trust Company comme trustees, et la W.K. Kellogg Foundation comme b茅n茅ficiaire unique.
Der W.K. Kellogg Foundation Trust meldete den Verkauf von 114.599 Aktien der Kellanova-Stammaktien am 28.08.2025 zum Preis von $79,5546 je Aktie und verringerte damit die gemeldete Position des Trusts auf 45.097.438 Aktien. Die Meldung weist den Trust als meldungspflichtige Person mit Direktorenstatus und als 10%-Eigent眉mer aus. In Formular 4 wird angegeben, dass die Verk盲ufe gem盲脽 Handelsanweisungen vom 7. Mai 2024 ausgef眉hrt wurden, die der Regel 10b5-1(c) entsprechen sollen. Als Treuh盲nder werden LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas und The Northern Trust Company aufgef眉hrt, und alleinige Beg眉nstigte ist die W.K. Kellogg Foundation.
- Sale executed under a 10b5-1(c) plan, which provides an affirmative defense against insider trading allegations
- Full disclosure of transaction details: date, price ($79.5546), number of shares sold (114,599) and post-transaction holdings (45,097,438)
- Insider disposition of 114,599 shares by a related Trust, which investors may view as a sale by a major holder
- Form 4 does not provide information on the proportion of outstanding shares or how proceeds will be used
Insights
TL;DR Insider sale executed under an established 10b5-1 plan, indicating pre-set trading instructions rather than ad-hoc liquidation.
The Form 4 shows a non-derivative disposition of 114,599 Kellanova shares at $79.5546 each, leaving the Trust with 45,097,438 shares. The filing explicitly states the sale followed trading instructions dated May 7, 2024 and invokes the affirmative-defense conditions of Rule 10b5-1(c). From a governance perspective, reliance on a 10b5-1 plan helps mitigate concerns about selective insider timing, though investors may still note the insider sale amount and continued large beneficial ownership by the Trust.
TL;DR A routine insider disposition under an existing plan; transaction is informational but not clearly materially adverse.
The reported sale is clearly disclosed with transaction date, price and post-transaction holdings. The Trust remains a substantial holder at 45,097,438 shares. The filing provides sufficient specificity on the amount sold and the 10b5-1 instruction date, but does not include context such as proportion of total shares outstanding or proceeds allocation, so market impact cannot be assessed from this Form 4 alone.
Il W.K. Kellogg Foundation Trust ha comunicato la vendita di 114.599 azioni ordinarie Kellanova in data 28/08/2025 al prezzo di $79,5546 per azione, riducendo la posizione dichiarata del Trust a 45.097.438 azioni. Il deposito identifica il Trust come persona soggetta a comunicazione con status di amministratore e con una partecipazione del 10%. Il Modulo 4 indica che le vendite sono state effettuate in base a istruzioni di negoziazione impartite il 7 maggio 2024, volte a conformarsi alla Regola 10b5-1(c). Nel deposito sono elencati come fiduciari LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas e The Northern Trust Company, mentre beneficiaria unica risulta la W.K. Kellogg Foundation.
El W.K. Kellogg Foundation Trust inform贸 la venta de 114.599 acciones ordinarias de Kellanova el 28/08/2025 a un precio de $79,5546 por acci贸n, reduciendo la posici贸n declarada del Trust a 45.097.438 acciones. la presentaci贸n identifica al Trust como persona obligada a informar con estatus de director y un propietario del 10%. El Formulario 4 indica que las ventas se ejecutaron conforme a instrucciones de negociaci贸n dadas el 7 de mayo de 2024, destinadas a cumplir con la Regla 10b5-1(c). La presentaci贸n enumera como fiduciarios a LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas y The Northern Trust Company, y a la W.K. Kellogg Foundation como beneficiaria 煤nica.
W.K. Kellogg Foundation Trust電� 2025雲� 8鞗� 28鞚� Kellanova 氤错喌欤� 114,599欤茧ゼ 欤茧嫻 $79.5546鞐� 毵る弰頄堧嫟瓿� 氤搓碃頄堨溂氅�, 鞚措鞃� 鞁犿儊鞚� 氤搓碃霅� 氤挫湢霟夓潃 45,097,438欤�搿� 欷勳棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞁犿儊鞚� 鞚挫偓 歆�鞙� 氚� 10% 靻岇湢鞛愲靹� 鞁犼碃 雽�靸侅瀯鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕 4電� 頃措嫻 毵る弰臧� 2024雲� 5鞗� 7鞚检棎 鞝滉车霅� 瓯半灅 歆�旃棎 霐半澕 鞁ろ枆霅橃棃鞙茧┌ 鞚措姅 攴滌箼 10b5-1(c)鞚� 欷�靾橅晿旮� 鞙勴暅 瓴冹澊霛缄碃 氚濏様鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞁犿儊甏�毽澑鞙茧 LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas 氚� The Northern Trust Company臧� 旮办灛霅橃柎 鞛堨溂氅�, 雼弲 靾橃澋鞛愲姅 W.K. Kellogg Foundation鞛呺媹雼�.
Le W.K. Kellogg Foundation Trust a d茅clar茅 la vente de 114 599 actions ordinaires Kellanova le 28/08/2025 au prix de 79,5546 $ par action, r茅duisant la position d茅clar茅e du Trust 脿 45 097 438 actions. Le d茅p么t identifie le Trust comme une personne tenue de d茅clarer, avec le statut d'administrateur et en tant que propri茅taire de 10 %. Le formulaire 4 indique que les ventes ont 茅t茅 ex茅cut茅es conform茅ment aux instructions de n茅gociation donn茅es le 7 mai 2024, visant 脿 se conformer 脿 la r猫gle 10b5-1(c). Le d茅p么t 茅num猫re LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas et The Northern Trust Company comme trustees, et la W.K. Kellogg Foundation comme b茅n茅ficiaire unique.
Der W.K. Kellogg Foundation Trust meldete den Verkauf von 114.599 Aktien der Kellanova-Stammaktien am 28.08.2025 zum Preis von $79,5546 je Aktie und verringerte damit die gemeldete Position des Trusts auf 45.097.438 Aktien. Die Meldung weist den Trust als meldungspflichtige Person mit Direktorenstatus und als 10%-Eigent眉mer aus. In Formular 4 wird angegeben, dass die Verk盲ufe gem盲脽 Handelsanweisungen vom 7. Mai 2024 ausgef眉hrt wurden, die der Regel 10b5-1(c) entsprechen sollen. Als Treuh盲nder werden LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas und The Northern Trust Company aufgef眉hrt, und alleinige Beg眉nstigte ist die W.K. Kellogg Foundation.
FAQ
What did the W.K. Kellogg Foundation Trust report in the Form 4 for Kellanova (K)?
Was the insider sale by the Trust executed under a 10b5-1 plan?
Who are the trustees or reporting individuals named in the Form 4?
What is the post-transaction ownership reported by the Trust?
Does the Form 4 include derivative transactions or amendments?
